RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Recent trends in urgent antibacterial threat-related hospitalization in the US
Reese, E., Kurosky, S., & Candrilli, S. (2015). Recent trends in urgent antibacterial threat-related hospitalization in the US. Value in Health, 18(3), A234-A235. https://doi.org/10.1016/j.jval.2015.03.1365
Antibiotic resistance (ABR) poses a threat to public health in the United States (US). The Centers for Disease Control and Prevention has identified three ABR urgent threats (defined as potential clinical and economic impact, transmissibility, available treatment, barriers to prevention): Clostridium difficile (C. diff), carbapenem-resistent Enterobacteriaceae (CRE), and Neisseria gonorrhoeae (N. gonorrhoeae). Limited data exist which document ABR-related burden in the context of inpatient care.